These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25972570)

  • 1. Detection of Antibodies Directed to the N-Terminal Region of GAD Is Dependent on Assay Format and Contributes to Differences in the Specificity of GAD Autoantibody Assays for Type 1 Diabetes.
    Williams AJ; Lampasona V; Schlosser M; Mueller PW; Pittman DL; Winter WE; Akolkar B; Wyatt R; Brigatti C; Krause S; Achenbach P;
    Diabetes; 2015 Sep; 64(9):3239-46. PubMed ID: 25972570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivity to N-Terminally Truncated GAD65(96-585) Identifies GAD Autoantibodies That Are More Closely Associated With Diabetes Progression in Relatives of Patients With Type 1 Diabetes.
    Williams AJ; Lampasona V; Wyatt R; Brigatti C; Gillespie KM; Bingley PJ; Achenbach P
    Diabetes; 2015 Sep; 64(9):3247-52. PubMed ID: 26001397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The first 142 amino acids of glutamate decarboxylase do not contribute to epitopes recognized by autoantibodies associated with Type 1 diabetes.
    Wyatt RC; Brigatti C; Liberati D; Grace SL; Gillard BT; Long AE; Marzinotto I; Shoemark DK; Chandler KA; Achenbach P; Gillespie KM; Piemonti L; Lampasona V; Williams AJK
    Diabet Med; 2018 Jul; 35(7):954-963. PubMed ID: 29577424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice.
    Bonifacio E; Atkinson M; Eisenbarth G; Serreze D; Kay TW; Lee-Chan E; Singh B
    Diabetes; 2001 Nov; 50(11):2451-8. PubMed ID: 11679421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12.
    Achenbach P; Hawa MI; Krause S; Lampasona V; Jerram ST; Williams AJK; Bonifacio E; Ziegler AG; Leslie RD;
    Diabetologia; 2018 Jul; 61(7):1644-1649. PubMed ID: 29619531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly-sensitive and specific enzyme-linked immunosorbent assays for GAD65 autoantibodies using a thioredoxin-GAD65 fusion antigen.
    Papouchado ML; Valdez SN; Ermácora MR; Gañan S; Poskus E
    J Immunol Methods; 1997 Sep; 207(2):169-78. PubMed ID: 9368643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GAD autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetes.
    Mayr A; Schlosser M; Grober N; Kenk H; Ziegler AG; Bonifacio E; Achenbach P
    Diabetes; 2007 Jun; 56(6):1527-33. PubMed ID: 17325256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of two nonisotopic immunoassays for determination of glutamic acid decarboxylase and tyrosine phosphatase autoantibodies in serum.
    Palomer X; Mauricio D; Rodríguez-Espinosa J; Zapico E; Mayoral C; González-Sastre F; de Leiva A; Blanco-Vaca F
    Clin Chem; 2004 Aug; 50(8):1378-82. PubMed ID: 15155543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maturation of the humoral autoimmune response to epitopes of GAD in preclinical childhood type 1 diabetes.
    Bonifacio E; Lampasona V; Bernasconi L; Ziegler AG
    Diabetes; 2000 Feb; 49(2):202-8. PubMed ID: 10868936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-resolved immunofluorometric dual-label assay for simultaneous detection of autoantibodies to GAD65 and IA-2 in children with type 1 diabetes.
    Ankelo M; Westerlund A; Blomberg K; Knip M; Ilonen J; Hinkkanen AE
    Clin Chem; 2007 Mar; 53(3):472-9. PubMed ID: 17259239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop.
    Verge CF; Stenger D; Bonifacio E; Colman PG; Pilcher C; Bingley PJ; Eisenbarth GS
    Diabetes; 1998 Dec; 47(12):1857-66. PubMed ID: 9836516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77.
    Desai M; Cull CA; Horton VA; Christie MR; Bonifacio E; Lampasona V; Bingley PJ; Levy JC; Mackay IR; Zimmet P; Holman RR; Clark A
    Diabetologia; 2007 Oct; 50(10):2052-60. PubMed ID: 17657474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LIPS islet autoantibody assays in high-throughput format for DASP 2010.
    Marcus P; Yan X; Bartley B; Hagopian W
    Diabetes Metab Res Rev; 2011 Nov; 27(8):891-4. PubMed ID: 22069280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies to N-terminally Truncated GAD65(96-585): HLA Associations and Predictive Value for Type 1 Diabetes.
    Pöllänen PM; Härkönen T; Ilonen J; Toppari J; Veijola R; Siljander H; Knip M
    J Clin Endocrinol Metab; 2022 Feb; 107(3):e935-e946. PubMed ID: 34747488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM.
    Grubin CE; Daniels T; Toivola B; Landin-Olsson M; Hagopian WA; Li L; Karlsen AE; Boel E; Michelsen B; Lernmark A
    Diabetologia; 1994 Apr; 37(4):344-50. PubMed ID: 8063033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives].
    Kretowski A; Kowalska I; Peczyńska J; Urban M; Kinalska I
    Przegl Lek; 2000; 57(3):143-6. PubMed ID: 10909282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence and predictive value of GAD65 autoantibodies and their correlation with HLA DR-DQ genotypes in children with type-1 diabetes].
    Hermann R; Gombos Z; Gyürüs E; Soltész G
    Orv Hetil; 2003 Feb; 144(8):355-60. PubMed ID: 12666382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GAD autoantibody affinity in schoolchildren from the general population.
    Bender C; Schlosser M; Christen U; Ziegler AG; Achenbach P
    Diabetologia; 2014 Sep; 57(9):1911-8. PubMed ID: 24939430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrepancy of glutamic acid decarboxylase 65 autoantibody results between RSR radioimmunoassay and enzyme-linked immunosorbent assay in patients with type 1 diabetes is related to autoantibody affinity.
    Kawasaki E; Okada A; Uchida A; Fukuyama T; Sagara Y; Nakano Y; Tamai H; Tojikubo M; Koga N
    J Diabetes Investig; 2019 Jul; 10(4):990-996. PubMed ID: 30582775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GAD65 autoantibodies detected by electrochemiluminescence assay identify high risk for type 1 diabetes.
    Miao D; Guyer KM; Dong F; Jiang L; Steck AK; Rewers M; Eisenbarth GS; Yu L
    Diabetes; 2013 Dec; 62(12):4174-8. PubMed ID: 23974918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.